Highlights
- ‘CAPS-AD’ is a novel vehicle of community-based treatment for alcohol and drugs in Brazil.
- We assessed a ‘snapshot sample’ of CAPS-AD clients in Brasilia (capital of Brazil).
- Most clients were male, middle-aged, unemployed, with alcohol or crack-cocaine problems.
- Half engaged in their first-ever treatment episode, suggesting effective reach by the CAPS-AD.
- Concerns about care structures, logistics and staff attitudes may compromise client retention.
Background
Substance
use is common in Brazil. In order to improve availability of substance misuse
care services, over 400 Psycho-Social Care Centres for Alcohol and Drugs
(CAPS-AD) – providing community-based care – have been established following
mental health care reform (2001). Information on CAPS-AD clients and outcomes
is limited. The present study examined select characteristics of local CAPS-AD
clients.
Methods
N = 143
adult CAPS-AD clients in Ceilândia (suburb of Brasília, Federal District)
participated in a 1-week ‘snapshot’ assessment of service users (February
2015). Following consent, descriptive data were collected by a brief, anonymous
interviewer-administered questionnaire that included socio-demographic, drug
use, treatment history and needs/barriers information.
Results
Participants
were predominantly male; middle-aged; unemployed; married; with middle-school
education; primary problem drugs indicated were alcohol and cocaine/crack; half
had prior treatment histories and indicated that treatment was externally
motivated; 60% reported ways to improve treatment and possible reasons for
treatment discontinuation; in multi-variate analyses, the latter was associated
with employment and education status (both p < .05).
Conclusion
CAPS-AD
services appear to have increased low-barrier substance misuse treatment
availability in Brazil, as well as attract individuals new to the treatment
system. Various potential barriers to continuing in treatment should be
addressed and more research on CAPS-AD clients and outcomes is needed.
Purchase full article at: http://goo.gl/GrJYEZ
By: Andrea Donatti Gallassi, Eduardo
Yoshio Nakano, Gabriela Arantes
Wagner, Maria de Nazareth Rodrigues
Malcher de Oliveira Silva, Benedikt
Fischer
Affiliations
Center of Drugs and Associated Vulnerabilities, Faculty of
Ceilândia, University of Brasilia, Brazil
Science and Health Technology Program, Faculty of Ceilândia,
University of Brasilia, Brazil
Correspondence
Corresponding author at: Center of Drugs and Associated
Vulnerabilities, University of Brasília (UNB), Faculty of Ceilândia, Centro
Metropolitano 1, Conjunto A – Ceilândia Sul Zip 72220-900, Brasília DF, Brazil.
Tel.: +55 6133770615.
More at: https://twitter.com/hiv insight
No comments:
Post a Comment